Citation: Ms. El-sayed et W. Nieuwenhuizen, The effect of alcohol ingestion on the exercise-induced changes in fibrin and fibrinogen degradation products in man, BL COAG FIB, 11(4), 2000, pp. 359-365
Authors:
Mac Gillavry, MR
Sanson, BJ
de Monye, W
Lijmer, JG
Huisman, MV
Buller, HR
Nieuwenhuizen, W
Brandjes, DPM
Citation: Mr. Mac Gillavry et al., Use of a new monoclonal antibody-based enzyme immunoassay for soluble fibrin to exclude pulmonary embolism, THROMB HAEM, 84(3), 2000, pp. 474-477
Authors:
Mac Gillavry, MR
de Monye, W
Lijmer, JG
Nieuwenhuizen, W
Buller, HR
Huisman, MV
Brandjes, DPM
Citation: Mr. Mac Gillavry et al., Clinical evaluation of a monoclonal antibody-based enzyme immunoassay for fibrin degradation products in patients with clinically suspected pulmonaryembolism, THROMB HAEM, 83(6), 2000, pp. 892-895
Authors:
de Maat, MPM
Meijer, P
Nieuwenhuizen, W
Haverkate, F
Kluft, C
Citation: Mpm. De Maat et al., Performance of semiquantitative and quantitative D-dimer assays in the ECAT External Quality Assessment Program, SEM THROMB, 26(6), 2000, pp. 625-630
Authors:
Yakovlev, S
Makogonenko, E
Kurochkina, N
Nieuwenhuizen, W
Ingham, K
Medved, L
Citation: S. Yakovlev et al., Conversion of fibrinogen to fibrin: Mechanism of exposure of tPA- and plasminogen-binding sites, BIOCHEM, 39(51), 2000, pp. 15730-15741
Authors:
Bos, R
Laterveer-Vreeswijk, GH
Lockwood, D
Szewczyk, K
Nieuwenhuizen, W
Citation: R. Bos et al., A new enzyme immunoassay for soluble fibrin in plasma, with a high discriminating power for thrombotic disorders, THROMB HAEM, 81(1), 1999, pp. 54-59